{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:32:24Z","timestamp":1764019944018},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":335,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust N Z J Obstet Gynaecol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1111\/ajo.12245","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T02:36:51Z","timestamp":1412649411000},"page":"453-456","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma"],"prefix":"10.1111","volume":"54","author":[{"given":"Thomas J.","family":"Cade","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Royal Women's Hospital; Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Royal Women's Hospital; Parkville Victoria Australia"},{"name":"Department of Obstetrics and Gynaecology; University of Melbourne; Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Rome","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Royal Women's Hospital; Parkville Victoria Australia"},{"name":"Obstetrics and Gynaecology Institute; Epworth Freemasons Hospital; Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Polyakov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Royal Women's Hospital; Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"key":"10.1111\/ajo.12245-BIB0001|ajo12245-cit-0001","doi-asserted-by":"crossref","first-page":"218.e.1","DOI":"10.1016\/j.ajog.2007.08.075","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/ajo.12245-BIB0002|ajo12245-cit-0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0003|ajo12245-cit-0003","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1111\/ajo.12245-BIB0004|ajo12245-cit-0004","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/0284186X.2012.689111","article-title":"Diagnosis and treatment of sarcoma of the uterus. A review","volume":"51","author":"Trop\u00e9","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1111\/ajo.12245-BIB0005|ajo12245-cit-0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/IGC.0b013e3181999c5f","article-title":"Endometrial stromal sarcoma: treatment and patterns of recurrence","volume":"19","author":"Thomas","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1111\/ajo.12245-BIB0006|ajo12245-cit-0006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2013.10.029","article-title":"Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases","volume":"132","author":"Yoon","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0007|ajo12245-cit-0007","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0090-8258(03)00258-0","article-title":"Low-grade endometrial stromal sarcoma: hormonal aspects","volume":"90","author":"Chu","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0008|ajo12245-cit-0008","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/sj.bjc.6603986","article-title":"Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma","volume":"97","author":"Amant","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1111\/ajo.12245-BIB0009|ajo12245-cit-0009","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00016348409156710","article-title":"Estradiol and progesterone receptors in gynecologic sarcomas","volume":"63","author":"Lantta","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/ajo.12245-BIB0010|ajo12245-cit-0010","first-page":"709","article-title":"Estrogen and progesterone receptors in uterine sarcomas","volume":"68","author":"Sutton","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1111\/ajo.12245-BIB0011|ajo12245-cit-0011","first-page":"75","article-title":"Estrogen receptor content, immunohistochemically determined by monoclonal antibodies, in endometrial stromal sarcoma","volume":"73","author":"Tosi","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1111\/ajo.12245-BIB0012|ajo12245-cit-0012","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1179\/joc.2003.15.6.596","article-title":"Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome","volume":"15","author":"Raspollini","year":"2003","journal-title":"J Chemother"},{"key":"10.1111\/ajo.12245-BIB0013|ajo12245-cit-0013","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2009.08.014","article-title":"Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles","volume":"115","author":"Ioffe","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0014|ajo12245-cit-0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2010.12.360","article-title":"Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy","volume":"121","author":"Cheng","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0015|ajo12245-cit-0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0090-8258(90)90267-O","article-title":"Uterine sarcoma: steroid receptors and response to hormonal therapy","volume":"39","author":"Wade","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0016|ajo12245-cit-0016","first-page":"729","article-title":"Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters","volume":"23","author":"Bodner","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1111\/ajo.12245-BIB0017|ajo12245-cit-0017","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13277-010-0138-1","article-title":"Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers","volume":"32","author":"Koivisto-Korander","year":"2011","journal-title":"Tumour Biol"},{"key":"10.1111\/ajo.12245-BIB0018|ajo12245-cit-0018","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9378(86)90086-4","article-title":"Endocrine aspects of human uterine sarcoma: a preliminary study","volume":"155","author":"Tseng","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/ajo.12245-BIB0019|ajo12245-cit-0019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2011.10.010","article-title":"Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment","volume":"125","author":"Beck","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajo.12245-BIB0020|ajo12245-cit-0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ygyno.2005.11.010","article-title":"Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature","volume":"101","author":"Pink","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajo.12245","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajo.12245\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T08:34:12Z","timestamp":1625301252000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajo.12245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ajo.12245","relation":{},"ISSN":["0004-8666"],"issn-type":[{"value":"0004-8666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}